ask="N/A"
ask_size="N/A"
average_daily_volume="44219"
bid="N/A"
bid_size="N/A"
book_value="0.811"
change="+0.025"
change_from_200_day_moving_average="-0.443"
change_from_50_day_moving_average="-0.089"
change_from_52_week_high="-2.515"
change_From_52_week_low="0.265"
change_in_percent="+1.712%"
close="1.485"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.260"
ebitda="-6.98M"
eps_estimate_current_year="-0.160"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.480"
ex_dividend_date="N/A"
float_shares="2446000"
high="1.485"
high_52_weeks="4.000"
last_trade_date="1/6/2017"
last_trade_price="1.485"
last_trade_size="100"
last_trade_time="3:23pm"
low="1.430"
low_52_weeks="1.220"
market_capitalization="16.32M"
moving_average_200_day="1.928"
moving_average_50_day="1.574"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.000"
open="1.435"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-22.977%"
percent_change_from_50_day_moving_average="-5.633%"
percent_change_from_52_week_high="-62.874%"
percent_change_from_52_week_low="+21.721%"
previous_close="1.460"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.800"
price_per_sales="4.223"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.620"
stock_exchange="NCM"
symbol="CBLI"
volume="6581"
weeks_range_52="1.220 - 4.000"
